As FDA Delays Ruling on Eli Lilly Drug, Clock Ticks on Plavix Patent

The FDA was supposed to decide this week whether to approve Eli Lilly’s blood thinner prasugrel, but the agency said yesterday that the decision would take another three months. It’s a complicated decision — in a big study, prasugrel was more effective than Plavix at preventing blood clots, but it also carried a greater risk [...]